Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The drawback of new immunotherapies in multiple sclerosis include severe infections that can be fatal. For example, treatment with natalizumab, which reduces the immune surveillance of the brain, can lead to the development of progressive multifocal leukoencephalopathy, a typically fatal form of viral encephalitis.

   

Today in Popular Press...keeping you current

Should flowers be banned in hospitals?
ScienceDaily, 12/18/09

Breakthrough May Pave the Way for Therapeutic Vaccines
ScienceDaily, 12/18/09

Negative emotions outweigh intent to exercise at health clubs
ScienceDaily, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address